DK0804465T3 - Nye elastaseinhibitorer - Google Patents

Nye elastaseinhibitorer

Info

Publication number
DK0804465T3
DK0804465T3 DK95918993T DK95918993T DK0804465T3 DK 0804465 T3 DK0804465 T3 DK 0804465T3 DK 95918993 T DK95918993 T DK 95918993T DK 95918993 T DK95918993 T DK 95918993T DK 0804465 T3 DK0804465 T3 DK 0804465T3
Authority
DK
Denmark
Prior art keywords
inhibitors
elastase inhibitors
elastase
compounds
new
Prior art date
Application number
DK95918993T
Other languages
English (en)
Inventor
Norton P Peet
Joseph P Burkhart
Michael R Angelastro
William A Metz Jr
Steven L Gallion
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0804465T3 publication Critical patent/DK0804465T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95918993T 1994-06-02 1995-05-05 Nye elastaseinhibitorer DK0804465T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25279994A 1994-06-02 1994-06-02
PCT/US1995/005618 WO1995033763A1 (en) 1994-06-02 1995-05-05 Novel elastase inhibitors

Publications (1)

Publication Number Publication Date
DK0804465T3 true DK0804465T3 (da) 2003-11-24

Family

ID=22957608

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95918993T DK0804465T3 (da) 1994-06-02 1995-05-05 Nye elastaseinhibitorer

Country Status (20)

Country Link
EP (1) EP0804465B1 (da)
JP (1) JP3623799B2 (da)
KR (1) KR100347285B1 (da)
CN (1) CN1149877A (da)
AT (1) ATE246708T1 (da)
AU (1) AU689589B2 (da)
CA (1) CA2189527C (da)
DE (1) DE69531459T2 (da)
DK (1) DK0804465T3 (da)
ES (1) ES2199992T3 (da)
FI (1) FI964781A7 (da)
HU (1) HU221197B1 (da)
IL (1) IL113940A (da)
NO (1) NO965097L (da)
NZ (1) NZ285565A (da)
PT (1) PT804465E (da)
SI (1) SI0804465T1 (da)
TW (1) TW403762B (da)
WO (1) WO1995033763A1 (da)
ZA (1) ZA954430B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4221059B2 (ja) * 1994-06-02 2009-02-12 アベンティス・インコーポレイテッド エラスターゼインヒビターのプロドラッグとしてのアシル化エノール誘導体
ES2137509T3 (es) * 1994-06-02 1999-12-16 Merrell Pharma Inc Perfluoroalquilcetonas, inhibidoras de elastasa y procedimientos para su preparacion.
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
NZ544076A (en) 2003-05-21 2009-04-30 Boehringer Ingelheim Int Hepatitis C inhibitor compounds
CA2573346C (en) 2004-07-20 2011-09-20 Boehringer Ingelheim International Gmbh Hepatitis c inhibitor peptide analogs
UY29016A1 (es) 2004-07-20 2006-02-24 Boehringer Ingelheim Int Analogos de dipeptidos inhibidores de la hepatitis c
MX2008014839A (es) 2006-05-23 2008-12-05 Irm Llc Compuestos y composiciones en la forma de inhibidores de proteasa de activacion mediante canal.
EA016327B1 (ru) * 2007-02-09 2012-04-30 Айрм Ллк Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы
EP4031138A1 (en) 2019-09-17 2022-07-27 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
DK4106757T3 (da) 2020-04-16 2023-10-23 Mereo Biopharma 4 Ltd Fremgangsmåder der involverer neutrofil elastase-inhibitor alvelestat til behandling af luftvejssygdom medieret af alpha-1-antitrypsin-mangel
JP2024540952A (ja) 2021-10-20 2024-11-06 メレオ バイオファーマ 4 リミテッド 線維化の治療における使用のための好中球エラスターゼ阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
CA2021660A1 (en) * 1989-07-26 1991-01-27 Philippe Bey Peptidase inhibitors
JPH06504547A (ja) * 1990-12-28 1994-05-26 ジョージア・テック・リサーチ・コーポレーション ペプチドケトアミド、ケト酸およびケトエステル
AU655831B2 (en) * 1991-08-22 1995-01-12 Merrell Pharmaceuticals Inc. Novel orally-active elastase inhibitors

Also Published As

Publication number Publication date
CA2189527C (en) 2000-12-19
NO965097L (no) 1997-01-31
DE69531459T2 (de) 2004-06-24
AU2470995A (en) 1996-01-04
NO965097D0 (no) 1996-11-29
CA2189527A1 (en) 1995-12-14
IL113940A0 (en) 1995-08-31
KR100347285B1 (ko) 2003-01-15
EP0804465A1 (en) 1997-11-05
CN1149877A (zh) 1997-05-14
TW403762B (en) 2000-09-01
DE69531459D1 (de) 2003-09-11
HU221197B1 (en) 2002-08-28
IL113940A (en) 1999-12-31
JP3623799B2 (ja) 2005-02-23
WO1995033763A1 (en) 1995-12-14
EP0804465B1 (en) 2003-08-06
FI964781L (fi) 1997-01-29
JPH10500992A (ja) 1998-01-27
SI0804465T1 (en) 2003-12-31
HUT76926A (hu) 1998-01-28
ZA954430B (en) 1996-02-13
MX9606030A (es) 1998-05-31
FI964781A0 (fi) 1996-11-29
HU9603312D0 (en) 1997-01-28
FI964781A7 (fi) 1997-01-29
AU689589B2 (en) 1998-04-02
ATE246708T1 (de) 2003-08-15
PT804465E (pt) 2003-12-31
NZ285565A (en) 1998-08-26
ES2199992T3 (es) 2004-03-01

Similar Documents

Publication Publication Date Title
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR0013966A (pt) Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
DK0793674T3 (da) Inhibitorer af human neutrofil elastase
BG101841A (bg) Инхибитори на клетъчна адхезия
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
TR199902622T2 (xx) Enflamatuvar hastal�klar�n tedavisinde faydal� ikameli imidazoller.
DK0804465T3 (da) Nye elastaseinhibitorer
ES2192839T3 (es) Timosina beta 4 oxidada.
NO934218L (no) Inhibitorer av cathepsin g og elastase for forhindring av bindevevsned-brytning
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
DE69629023D1 (de) Piperazino-derivative als neurokininantagonisten
ES2142490T3 (es) Ciclopeptolidos.
DE69931784D1 (de) Chemotaxis hemmendes protein von staphylococcus aureus (chips) und dessen verwendung
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
AP2000001760A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
BRPI0415355A (pt) triarilimidazóis
DE69726743D1 (de) Peptid analoge, die einen siebengliedrigen lactamring enthalten
EA200100152A1 (ru) Замещенные пиперазиноны и их терапевтическое применение
FI972673A7 (fi) 4,4-(disubstituoitu)sykloheksan-1-oli-monomeereja ja vastaavia yhdiste itä
PT1358182E (pt) Derivados de diazocinas e sua utilizacao como inibidores de triptase
MX9606031A (es) Inhibidores de cetona perfluoroalquilica de elastasa y procesos para fabricarlos.